Public health experts are calling for more transparency in the drug approval system and the overall drug regulatory framework in the country, in the wake of the recent episode in which the Central Bureau of Investigation (CBI)...
How are players getting into new geographies & developing innovative products to succeed in the growing competitive veterinary medicine market.
US health officials said they have agreed to purchase another 105 million doses of Pfizer's COVID-19 vaccine in anticipation of a fall booster campaign...
Eli Lilly to supply additional doses of COVID antibody drug to U.S.Eli Lilly and Co said on Wednesday it will supply additional doses of its COVID-19 antibody drug to the U.S. government in order to meet demand through late August....
Hyderabad based conglomerate INCOR Group and Renovis Labs, promoted by Prof. Javed Iqbal - country’s esteemed scientist, have entered into a new JV ‘INCOR Renovis’...
Pharma firm Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said....
AstraZeneca said two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the firm’s oncology portfolio...
The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer, developed by the Serum Institute, official sources said on Sunday...
Pharma R&D is now traversing towards progressive analysis. In this post we have listed top three technologies that will avail the same.
Dr. Reddy’s announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois, based Eton Pharmaceuticals. Under the terms of the agreement, Dr. Reddy’s will pay $5 million upfront in cash, plus contingent
, CDSCO.jpg)
